Dr. Papageorgiou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Hospital Dr
Columbia, MO 65212Phone+1 573-882-2100Fax+1 573-884-7822
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1999 - 2002
- Westchester Medical CenterResidency, Internal Medicine, 1996 - 1999
- Aristotle University of Thessaloniki School of MedicineClass of 1994
Certifications & Licensure
- MO State Medical License 2002 - 2026
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 1 citationsUnderstanding common key indicators of successful and unsuccessful cancer drug trials using a contrast mining framework on ClinicalTrials.gov.Shu-Kai Chang, Danlu Liu, Jonathan Mitchem, Christos Papageorgiou, Jussuf Kaifi
Journal of Biomedical Informatics. 2023-03-01 - 3 citationsImmune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery.Olha Kholod, William I Basket, Jonathan B Mitchem, Jussuf T Kaifi, Richard D Hammer
Cancers. 2022-11-25 - TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer.Yuanyuan Shen, Yulia I Nussbaum, Yariswamy Manjunath, Justin J Hummel, Matthew A Ciorba
Cancers. 2022-09-22
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: